|
| |
| | | 69936 | | 08.08.2024 | | Hasten Biopharmaceutic (Switzerland) AG | | | | | | | | | | | | | | | | | 02.07.10. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Hanarbe 20 mg | Tabletten | Tabletten (Azilsartanum Medoxomilum 20 mg) | C09CA09 | PI | | 02 | Hanarbe 40 mg | Tabletten | Tabletten (Azilsartanum Medoxomilum 40 mg) | C09CA09 | | | 03 | Hanarbe 80 mg | Tabletten | Tabletten (Azilsartanum Medoxomilum 80 mg) | C09CA09 | |
|
|
|
